Literature DB >> 2730600

Cerebral ischemia in the developing primate fetus.

R E Myers1.   

Abstract

The common carotid arteries and jugular veins of fetuses of dated rhesus monkey pregnancies were ligated at different times during the last 2/3's of gestation. Fetuses that survived were delivered surgically at term and their brains examined pathologically. The findings obtained demonstrated the following principles: 1. Production of ischemia of the anterior cerebral circulation by bilateral ligation of the common carotid arteries and jugular veins prior to the end of the first half of gestation (82 days) produced brain abnormalities in all instances. 2. Ligation of the common carotid arteries and jugular veins during the middle 1/3 of gestation (55-110 days) produced 1) extensive focal tissue destruction restricted to the ischemic territory in 6 of 12 fetuses and 2) abnormal brain development in 3 of 12 fetuses. 3. Ligation of the common carotid arteries and jugular veins early during the middle 1/3 of gestation favored the occurrence of cerebral dysgenesis or brain malformation while late during the middle 1/3 it favored focal tissue destruction. In the earlier cases of blood vessel ligation the focal tissue destruction resembled hydranencephaly. 4. Production of ischemia of the anterior cerebral circulation by ligation of the common carotid arteries and jugular veins during the last 1/3 of gestation (greater than 110 days) produced no gross or microscopic brain abnormalities.

Entities:  

Mesh:

Year:  1989        PMID: 2730600

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  2 in total

Review 1.  Hemihydranencephaly: rare disease with key to secrets of the brain.

Authors:  Lorraine S Dias; K N Shivashankara; G Vivek
Journal:  BMJ Case Rep       Date:  2011-03-24

Review 2.  Hemihydranencephaly: living with half brain dysfunction.

Authors:  Piero Pavone; Francesco Nigro; Raffaele Falsaperla; Filippo Greco; Martino Ruggieri; Renata Rizzo; Andrea D Praticò; Lorenzo Pavone
Journal:  Ital J Pediatr       Date:  2013-01-16       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.